Malignant Melanoma
Showing 1 - 25 of 202
Melanoma, Malignant Melanoma Trial (T3011 + Cobimetinib)
Not yet recruiting
- Melanoma
- Malignant Melanoma
- T3011 + Cobimetinib
- (no location specified)
Mar 3, 2023
Advanced Solid Tumor, Castration-Resistant Prostatic Cancer, Malignant Melanoma Trial in United States (MGC018, lorigerlimab)
Recruiting
- Advanced Solid Tumor
- +6 more
- vobramitamab duocarmazine
- lorigerlimab
-
Los Angeles, California
- +7 more
Jan 10, 2023
Advanced Solid Tumor, Non Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma Trial in United States (STK-012,
Recruiting
- Advanced Solid Tumor
- +10 more
-
Boston, Massachusetts
- +8 more
Jan 2, 2023
Malignant Melanoma, Liver Metastases Trial (Recombinant Human Adenovirus Type 5 Injection,Camrelizumab,Nab-paclitaxel)
Not yet recruiting
- Malignant Melanoma
- Liver Metastases
- Recombinant Human Adenovirus Type 5 Injection,Camrelizumab,Nab-paclitaxel
- (no location specified)
Dec 23, 2022
Malignant Melanoma, Merkel Cell Carcinoma Trial in Bern (Visionsense™ VS3 - Stereoscopic High Definition Visualisation System
Completed
- Malignant Melanoma
- Merkel Cell Carcinoma
- Visionsense™ VS3 - Stereoscopic High Definition Visualisation System (VS3-3DHD)
-
Bern, Kanton Bern, SwitzerlandInselspital, University Hospital Bern, University of Bern
Dec 7, 2022
Malignant Melanoma, Melanoma (Skin), Melanoma Stage III Trial in United Kingdom (SCIB1 DNA vaccine)
Recruiting
- Malignant Melanoma
- +3 more
- SCIB1 DNA vaccine
-
Cardiff, United Kingdom
- +6 more
Dec 7, 2022
Malignant Melanoma, Angiosarcoma Trial in Chuo Ku (CICS-1 (investigational device),SPM-011(investigational drug))
Active, not recruiting
- Malignant Melanoma
- Angiosarcoma
- CICS-1 (investigational device),SPM-011(investigational drug)
-
Chuo Ku, Tokyo, JapanNational Cancer Center Hospital
Nov 6, 2022
Malignant Melanoma, BRAF V600 Mutation, Brain Metastases Trial in France (Stereotaxic radiosurgery (SRS), Binimetinib Oral
Recruiting
- Malignant Melanoma
- +2 more
- Stereotaxic radiosurgery (SRS)
- +3 more
-
Bobigny, France
- +20 more
Oct 7, 2022
Malignant Melanoma Trial in Herlev, Aarhus, Odense (Pembrolizumab Injection [Keytruda], Ipilimumab Injection [Yervoy], Nivolumab
Recruiting
- Malignant Melanoma
- Pembrolizumab Injection [Keytruda]
- +6 more
-
Herlev, Hovedstaden, Denmark
- +2 more
Sep 16, 2022
Malignant Melanoma Trial in Worldwide (Pembrolizumab, Lenvatinib, Placebo for lenvatinib)
Active, not recruiting
- Malignant Melanoma
- Pembrolizumab
- +2 more
-
Los Angeles, California
- +118 more
Aug 22, 2022
Malignant Melanoma Trial in Worldwide (UV1, Sargramostim, Ipilimumab)
Recruiting
- Malignant Melanoma
- UV1
- +3 more
-
Phoenix, Arizona
- +39 more
Aug 16, 2022
Malignant Melanoma, Gynecologic Cancer Trial in Pavia (carbon ion radiation therapy CIRT)
Recruiting
- Malignant Melanoma
- Gynecologic Cancer
- carbon ion radiation therapy CIRT
-
Pavia, ItalyCNAO
Jul 27, 2022
Gastric Adenocarcinoma, Malignant Melanoma Trial in Seoul (AZD6738, Durvalumab)
Active, not recruiting
- Gastric Adenocarcinoma
- Malignant Melanoma
-
Seoul, Korea, Republic ofSamsung Medical Center
Jun 13, 2022
Tafinlar® + Mekinist® (Dabrafenib + Trametinib)
Recruiting
- Malignant Melanoma
- dabrafenib + trametinib
-
Coimbra, Center, Portugal
- +5 more
Jun 9, 2022
Malignant Melanoma Trial in Aurora (Oral Decitabine/Cedazuridine (DEC-C) in Combination with Nivolumab)
Recruiting
- Malignant Melanoma
- Oral Decitabine/Cedazuridine (DEC-C) in Combination with Nivolumab
-
Aurora, ColoradoUniversity of Colorado Hospital
May 25, 2022
Skin Cancer, Malignant Melanoma Trial in Copenhagen (Reflectance confocal microscopy (RCM), Photoacoustic imaging (PAI) and
Recruiting
- Skin Cancer
- Malignant Melanoma
- Reflectance confocal microscopy (RCM), Photoacoustic imaging (PAI) and tape-strippng of RNA and lipids
-
Copenhagen, DenmarkDept of Dermatology
May 20, 2022
Malignant Melanoma, Brain Metastases Trial in Tucson (E6201, E6201 plus dabrafenib)
Terminated
- Malignant Melanoma
- Brain Metastases
- E6201
- E6201 plus dabrafenib
-
Tucson, ArizonaUniversity of Arizona Cancer Center
Mar 5, 2022
Malignant Melanoma Trial in Milan (Pembrolizumab)
Recruiting
- Malignant Melanoma
- Pembrolizumab
-
Milan, ItalyIEO Istituto Europeo di Oncologia
May 12, 2022
Diagnostic Precision of AI Tool Dermalyzer to Identify Malignant
Recruiting
- Malignant Melanoma
- Dermalyzer
-
Linköping, Docent, Sweden
- +2 more
May 12, 2022
Malignant Melanoma, Sinonasal Melanoma Trial in Shanghai (endoscopic surgery)
Recruiting
- Malignant Melanoma
- Sinonasal Melanoma
- endoscopic surgery
-
Shanghai, Shanghai, ChinaEye& ENT Hospital, Fudan University
May 8, 2022
SCLC, Malignant Melanoma, Sarcoma Trial (GD2-SADA:177Lu-DOTA Complex)
Not yet recruiting
- SCLC
- +2 more
- GD2-SADA:177Lu-DOTA Complex
- (no location specified)
May 4, 2022
The Gut Microbiome and Immune Checkpoint Inhibitor Therapy in
Recruiting
- Non-Small-Cell Lung Carcinoma
- +3 more
- Checkpoint Inhibitor, Immune
-
Elizabethtown, KentuckyBaptist Health Clinical Research
Apr 25, 2022